Combining drugs that target BRAF and HSP90 shows success for melanoma patients
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
List view / Grid view
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
When irradiated, less stiff extracellular matrices reduced cancer growth and migration, bolstering the case to further understand fractionated radiation therapy...
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies...
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months...
Data from a new study shows that repurposing drugs used to treat leukaemia has promise for preventing melanoma metastasis...
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
Study shows first applications of DNA origami for nanomedicine...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
Scientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcoma cells in the lab.